Advertisement Biocatalytic Technologies - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More

Biocatalytic Technologies

Johnson Matthey Fine Chemicals

JMCCT is delighted to provide an ever-growing, unique group of biocatalysts, that enhance the chiral capabilities of our chemo-catalyst technology offering.

This combined portfolio of catalytic technology, allows us to design the most effective synthetic route for our clients.

Click here to find out more.


Quick Contact Biocatalytic Technologies